News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies


6/24/2014 10:30:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent International (OMXS: BINV) today announced that the company has been granted a US patent covering the antibody drug candidate BI-505, initially in phase II development for the treatment of multiple myeloma. The patent has broad coverage and protects development of any apoptosis-inducing ICAM-1 antibody.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
BioInvent
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES